Angelini Group manufactures and markets pharmaceuticals and health-care products. The Fine Chemical Division is one of the major Italian CDMOs for cGMP 3rd party manufacturing S.M. Advance intermediates and NCEs for pharma market. Angelini manufacturing capability spans a wide chemical reaction portofolio and boasts novel process technologies, such as High Containment API and Flow Chemistry. With cutting-edge manufacturing facility and R&D labs our plant is housing multi-purpose synthesis unit and Kilo-labs comprising of over 50 reactors and 140 c.m. Established in Italy in 1919, Angelini has grown to become a medium-sized international group